Long-term studies show significant weight regain over 6-12 months of discontinuation, but a structured short break with proper weight maintenance strategies typically results in 3-8 pounds of regain, much of which is water weight and glycogen restoration that reverses quickly upon restarting medication
The most common adverse effects are gastrointestinal in nature, affecting up to 4050% of patients, particularly during treatment initiation or dose escalation
You have to do weight management if you want [GLP-1 drugs] for weight loss
While they share a genetic origin, their physiological targets are distinct
If you find yourself with expired vials regularly, discuss storage challenges or dosing frequency adjustments with your care team
These results highlight the significant benefits of adding tirzepatide to insulin therapy, offering improved glycemic control and meaningful weight loss in patients with T2DM who are inadequately controlled on insulin glargine alone [72]
